{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T07:43:37Z","timestamp":1792827817985,"version":"4.5.0"},"reference-count":34,"publisher":"American Society of Tropical Medicine and Hygiene","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,2]]},"abstract":"<jats:title>ABSTRACT.<\/jats:title>\n                  <jats:p>Cutaneous larva migrans (CLM) is a clinical syndrome typically found in tropical and subtropical regions. The objective of the study is to describe the epidemiological, clinical, and therapeutic characteristics of patients with CLM acquired during international travel. This retrospective observational study analyzes CLM cases treated at an international health unit in Spain. Sociodemographic, clinical, laboratory, and treatment-related data were collected. Overall, 107 cases were diagnosed, 63 (58.9%) of them in women, with a mean age of 32.6 years. Most frequent geographic regions of CLM acquisition were Southeast Asia (38 cases, 35.5%) and South America (28, 26.2%). Patients had a median of one skin lesion (range 1\u201311) located mainly in the lower extremities (83, 77.6%). Treatment was administered in 105 cases (98.1%), with albendazole used in 88 (83.8%), ivermectin in nine (8.6%), mebendazole in six (5.7%), and two cases lacking drug information (1.9%). Among treated cases, clinical resolution was achieved in 88 (83.8%) patients. Symptoms persisted in 17 (16.2%) cases, and recurrence was observed in 14 (13.3%) cases. A total of 26 (24.8%) patients required re-treatment with either albendazole or ivermectin (61.5% and 38.5%, respectively). The resolution rates for ivermectin, albendazole, and mebendazole were 88.9%, 88.6%, and 0.0%, respectively. CLM is a common syndrome in certain geographic regions and is more frequently diagnosed in international travelers. A thorough epidemiological assessment, along with a detailed medical history and physical examination, facilitates early diagnosis and treatment. Currently, ivermectin and albendazole appear to achieve the highest cure rates with lower recurrence rates.<\/jats:p>","DOI":"10.4269\/ajtmh.24-0856","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T16:33:38Z","timestamp":1746549218000},"page":"81-85","source":"Crossref","is-referenced-by-count":2,"title":["Imported Cutaneous Larva Migrans: Epidemiological, Clinical, and Therapeutic Aspects Analyzed in a Referral Tropical Medicine Unit in Barcelona"],"prefix":"10.4269","volume":"113","author":[{"given":"David","family":"L\u00f3pez-Neila","sequence":"first","affiliation":[{"name":"International Health Unit Vall d\u2019Hebron-Drassanes,Department of Infectious Diseases, Vall d\u2019Hebron University Hospital, PROSICS Barcelona, Barcelona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Salvador","sequence":"additional","affiliation":[{"name":"International Health Unit Vall d\u2019Hebron-Drassanes,Department of Infectious Diseases, Vall d\u2019Hebron University Hospital, PROSICS Barcelona, Barcelona, Spain;"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Mart\u00ednez-Campreci\u00f3s","sequence":"additional","affiliation":[{"name":"International Health Unit Vall d\u2019Hebron-Drassanes,Department of Infectious Diseases, Vall d\u2019Hebron University Hospital, PROSICS Barcelona, Barcelona, Spain;"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Luisa","family":"Aznar","sequence":"additional","affiliation":[{"name":"International Health Unit Vall d\u2019Hebron-Drassanes,Department of Infectious Diseases, Vall d\u2019Hebron University Hospital, PROSICS Barcelona, Barcelona, Spain;"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Espinosa-Pereiro","sequence":"additional","affiliation":[{"name":"International Health Unit Vall d\u2019Hebron-Drassanes,Department of Infectious Diseases, Vall d\u2019Hebron University Hospital, PROSICS Barcelona, Barcelona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00e9s","family":"Oliveira-Souto","sequence":"additional","affiliation":[{"name":"International Health Unit Vall d\u2019Hebron-Drassanes,Department of Infectious Diseases, Vall d\u2019Hebron University Hospital, PROSICS Barcelona, Barcelona, Spain;"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pau","family":"Bosch-Nicolau","sequence":"additional","affiliation":[{"name":"International Health Unit Vall d\u2019Hebron-Drassanes,Department of Infectious Diseases, Vall d\u2019Hebron University Hospital, PROSICS Barcelona, Barcelona, Spain;"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Pou","sequence":"additional","affiliation":[{"name":"International Health Unit Vall d\u2019Hebron-Drassanes,Department of Infectious Diseases, Vall d\u2019Hebron University Hospital, PROSICS Barcelona, Barcelona, Spain;"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adri\u00e1n","family":"S\u00e1nchez-Montalv\u00e1","sequence":"additional","affiliation":[{"name":"International Health Unit Vall d\u2019Hebron-Drassanes,Department of Infectious Diseases, Vall d\u2019Hebron University Hospital, PROSICS Barcelona, Barcelona, Spain;"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00faria","family":"Serre-Delcor","sequence":"additional","affiliation":[{"name":"International Health Unit Vall d\u2019Hebron-Drassanes,Department of Infectious Diseases, Vall d\u2019Hebron University Hospital, PROSICS Barcelona, Barcelona, Spain;"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bego\u00f1a","family":"Trevi\u00f1o","sequence":"additional","affiliation":[{"name":"International Health Unit Vall d\u2019Hebron-Drassanes,Department of Infectious Diseases, Vall d\u2019Hebron University Hospital, PROSICS Barcelona, Barcelona, Spain;"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israel","family":"Molina","sequence":"additional","affiliation":[{"name":"International Health Unit Vall d\u2019Hebron-Drassanes,Department of Infectious Diseases, Vall d\u2019Hebron University Hospital, PROSICS Barcelona, Barcelona, Spain;"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2795","reference":[{"key":"b1","series-title":"Int Marit Health","first-page":"259","article-title":"Cutaneous larva migrans as a frequent problem in travelers","volume":"74","author":"Kuna","year":"2023"},{"key":"b2","series-title":"Lancet Infect Dis","first-page":"302","article-title":"Epidemiological and clinical characteristics of hookworm-related cutaneous larva migrans","volume":"8","author":"Heukelbach","year":"2008"},{"key":"b3","series-title":"Eur J Dermatol","first-page":"426","article-title":"Cutaneous larva migrans: A case in Bordeaux, France, and a systematic review of locally acquired cases in Europe","volume":"27","author":"Blaizot","year":"2017"},{"key":"b4","series-title":"Actas Dermosifiliogr","first-page":"407","article-title":"Autochthonous cutaneous larva migrans infection in Guip\u00fazcoa","volume":"107","author":"Pan\u00e9s-Rodr\u00edguez","year":"2016"},{"key":"b5","series-title":"N Engl J Med","first-page":"e16","article-title":"Images in Clinical Medicine. Creeping eruption\u2013cutaneous larva migrans","volume":"374","author":"Ma","year":"2016"},{"key":"b6","series-title":"Br J Dermatol","first-page":"434","article-title":"Cutaneous larva migrans: Clinical features and management of 44 cases presenting in the returning traveler","volume":"145","author":"Blackwell","year":"2001"},{"key":"b7","series-title":"J Travel Med","first-page":"tav021","article-title":"Prolonged incubation period of hookworm-related cutaneous larva migrans","volume":"23","author":"Chris","year":"2016"},{"key":"b8","series-title":"Drugs for Parasitic Infections","year":"2013"},{"key":"b9","series-title":"Travel Med Infect Dis","first-page":"382","article-title":"Management of imported cutaneous larva migrans: A case series and mini-review","volume":"13","author":"Kincaid","year":"2015"},{"key":"b10","series-title":"Int J Dermatol","first-page":"67","article-title":"Treatment of larva migrans cutanea (creeping eruption): A comparison between albendazole and traditional therapy","volume":"40","author":"Albanese","year":"2001"},{"key":"b11","series-title":"Am J Trop Med Hyg","first-page":"757","article-title":"Spectrum of imported infectious diseases: A comparative prevalence study of 16,817 German travelers and 977 immigrants from the tropics and subtropics","volume":"94","author":"Herbinger","year":"2016"},{"key":"b12","series-title":"Travel Med Infect Dis","first-page":"61","article-title":"Epidemiological profile of cutaneous larva migrans in travelers returning to France between 2003 and 2015","volume":"20","author":"Sow","year":"2017"},{"key":"b13","series-title":"PLoS Negl Trop Dis","first-page":"e0006662","article-title":"Epidemiology and morbidity of hookworm-related cutaneous larva migrans (HrCLM): Results of a cohort study over a period of six months in a resource-poor community in Manaus, Brazil","volume":"12","author":"Reichert","year":"2018"},{"key":"b14","series-title":"Actas Dermo-Sifiliogr\u00e1ficas","first-page":"443","article-title":"Larva migrans cut\u00e1nea. Presentaci\u00f3n de 8 casos","volume":"93","author":"S\u00e0bat Santandreu","year":"2002"},{"key":"b15","series-title":"Clin Cosmet Investig Dermatol","first-page":"3375","article-title":"Cutaneous larva migrans: A One Health perspective on familial infection among tourists returning from Southeast Asia","volume":"16","author":"Sa\u0142amatin","year":"2023"},{"key":"b16","series-title":"Korean J Parasitol","first-page":"145","article-title":"Three clinical cases of cutaneous larva migrans","volume":"44","author":"Kim","year":"2006"},{"key":"b17","series-title":"Indian J Dermatol","first-page":"422","article-title":"Creeping eruption on the move: A case series from Northern India","volume":"60","author":"Kaur","year":"2015"},{"key":"b18","series-title":"Acta Derm Venereol","first-page":"805","article-title":"Autochthonous cutaneous larva migrans in France and Europe","volume":"99","author":"Del Giudice","year":"2019"},{"key":"b19","series-title":"BMJ Case Rep","first-page":"bcr2015210165","article-title":"Hookworm-related cutaneous larva migrans acquired in the UK","volume":"2015","author":"Baple","year":"2015"},{"key":"b20","series-title":"Infect Dis Rep","first-page":"215","article-title":"North Italy: Welcome to the tropics!","volume":"13","author":"Veronese","year":"2021"},{"key":"b21","series-title":"IDCases","first-page":"e01885","article-title":"Late relapse of cutaneous larva migrans","volume":"33","author":"Dam Larsen","year":"2023"},{"key":"b22","series-title":"Cases J","first-page":"7553","article-title":"Late presentation of cutaneous larva migrans: A case report","volume":"2","author":"Archer","year":"2009"},{"key":"b23","series-title":"J Travel Med","first-page":"taab136","article-title":"A cluster of cutaneous larva migrans in travelers returning from Zanzibar","volume":"29","author":"Korzeniewski","year":"2022"},{"key":"b24","series-title":"Pediatr Dermatol","first-page":"211","article-title":"Individual variability of the cutaneous larva migrans (CLM) incubation period","volume":"27","author":"Siriez","year":"2010"},{"key":"b25","series-title":"Korean J Parasitol","first-page":"233","article-title":"A serologically diagnosed human case of cutaneous larva migrans caused by Ancylostoma caninum","volume":"41","author":"Kwon","year":"2003"},{"key":"b26","series-title":"Trans R Soc Trop Med Hyg","first-page":"650","article-title":"Detection of antibodies to secretions of Ancylostoma caninum in human eosinophilic enteritis","volume":"86","author":"Loukas","year":"1992"},{"key":"b27","series-title":"Am J Trop Med Hyg","first-page":"672","article-title":"Immunoglobulin G subclass antibodies against excretory\/secretory antigens of Ancylostoma caninum in human enteric infections","volume":"54","author":"Loukas","year":"1996"},{"key":"b28","series-title":"Trop Med Infect Dis","first-page":"209","article-title":"Assessment of an immuno-diagnostic method for hookworm-related cutaneous larva migrans using crude extracts of Ancylostoma caninum","volume":"8","author":"Adam","year":"2023"},{"key":"b29","series-title":"Clin Infect Dis","first-page":"1062","article-title":"Cutaneous larva migrans in travelers: Synopsis of histories, symptoms, and treatment of 98 patients","volume":"19","author":"Jelinek","year":"1994"},{"key":"b30","series-title":"J Travel Med","first-page":"221","article-title":"What\u2019s new in travel-associated dermatology?","volume":"22","author":"Monsel","year":"2015"},{"key":"b31","series-title":"J Microbiol Immunol Infect","first-page":"100","article-title":"Treatment of larva migrans syndrome with long-term administration of albendazole","volume":"52","author":"Hombu","year":"2019"},{"key":"b32","series-title":"Clin Infect Dis","first-page":"1155","article-title":"Hookworm-related cutaneous larva migrans in northern Brazil: Resolution of clinical pathology after a single dose of ivermectin","volume":"57","author":"Schuster","year":"2013"},{"key":"b33","series-title":"Eur J Microbiol Immunol (Bp)","first-page":"258","article-title":"Hookworm-related cutaneous larva migrans in patients living in an endemic community in Brazil: Immunological patterns before and after ivermectin treatment","volume":"3","author":"Shimogawara","year":"2013"},{"key":"b34","series-title":"J Eur Acad Dermatol Venereol","first-page":"655","article-title":"The efficacy of single dose ivermectin in the treatment of hookworm related cutaneous larva migrans varies depending on the clinical presentation","volume":"28","author":"Vanhaecke","year":"2014"}],"container-title":["The American Journal of Tropical Medicine and Hygiene"],"original-title":[],"link":[{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/113\/1\/article-p81.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/113\/1\/article-p81.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/113\/1\/article-p81.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T09:55:28Z","timestamp":1751450128000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/113\/1\/article-p81.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":34,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.4269\/ajtmh.24-0856","relation":{},"ISSN":["0002-9637","1476-1645"],"issn-type":[{"value":"0002-9637","type":"print"},{"value":"1476-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]}}}